Transcriptomic profiling of breast tumors provides opportunity for subtyping and molecular-based patient stratification. In diagnostic applications the specimen profiled should be representative of the expression profile of the whole tumor and ideally capture properties of the most aggressive part of the tumor. | Intra-tumor heterogeneity in breast cancer has limited impact on transcriptomic-based molecular profiling